The efficacy of alpha-1A blocker (tamsulosin), antimuscarinic (solifenacin) and their combination in the management of double-J stent-related lower urinary tract symptoms: a randomized controlled study

被引：0
|
作者：
Elsayed M. Salih
Ayman K. Koritenah
Muhamed Yehya
Mourad M. Mourad
机构：
[1] Al-Azhar University,Department of Urology, Faculty of Medicine
来源：
African Journal of Urology | 2021年 / 27卷
关键词：
Tamsulosin; Solifenacin; Ureteral stent; Quality of life; Lower urinary tract symptoms;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The efficacy of alpha-1A blocker (tamsulosin), antimuscarinic (solifenacin) and their combination in the management of double-J stent-related lower urinary tract symptoms: a randomized controlled study
    Salih, Elsayed M.
    Koritenah, Ayman K.
    Yehya, Muhamed
    Mourad, Mourad M.
    AFRICAN JOURNAL OF UROLOGY, 2021, 27 (01)
  • [2] Randomized Controlled Trial to Compare the Safety and Efficacy of Tamsulosin, Solifenacin, and Combination of Both in Treatment of Double-J Stent-Related Lower Urinary Symptoms
    Shalaby, Essam
    Ahmed, Abul-fotouh
    Maarouf, Aref
    Yahia, Iman
    Ali, Mohamed
    Ghobish, Ammar
    ADVANCES IN UROLOGY, 2013, 2013
  • [3] Efficacy of Tamsulosin, Oxybutynin, and their combination in the control of double-j stent-related lower urinary tract symptoms
    Maldonado-Avila, Miguel
    Garduno-Arteaga, Leopoldo
    Jungfermann-Guzman, Rene
    Manzanilla-Garcia, Hugo A.
    Rosas-Nava, Emmanuel
    Procuna-Hernandez, Nestor
    Vela-Mollinedo, Alejandro
    Almazan-Trevino, Luis
    Guzman-Esquivel, Jose
    INTERNATIONAL BRAZ J UROL, 2016, 42 (03): : 487 - 493
  • [4] Re: Randomized Controlled Trial to Compare the Safety and Efficacy of Tamsulosin, Solifenacin, and Combination of Both in Treatment of Double-J Stent-Related Lower Urinary Symptoms
    Rezaei, Yousef
    INTERNATIONAL BRAZ J UROL, 2014, 40 (05): : 712 - 713
  • [5] Double-J stent-related lower urinary tract symptoms: a prospective randomized trial of mirabegron, solifenacin, tamsulosin, and tadalafil and their combinations
    Palinrungi, Muhammad A.
    Rasyid, Haerani
    Prihantono, Prihantono
    Cangara, Muhammad H.
    Bukhari, Agussalim
    Rahardjo, Harrina E.
    Syahrir, Syakri
    Zainuddin, Andi A.
    GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE, 2023, 182 (10) : 634 - 640
  • [6] EFFICACY OF TAMSULOSIN 0.4 MG IN RELIEVING OF DOUBLE-J STENT-RELATED SYMPTOMS: A RANDOMIZED CONTROLLED STUDY
    Lojanapiwat, Bannakij
    Navanimitkul, Niti
    JOURNAL OF ENDOUROLOGY, 2011, 25 : A74 - A74
  • [7] Tamsulosin, Solifenacin, and Their Combination for the Treatment of Stent-Related Symptoms: A Randomized Controlled Study
    Dellis, Athanasios E.
    Papatsoris, Athanasios G.
    Keeley, Francis X., Jr.
    Bamias, Aristotelis
    Deliveliotis, Charalambos
    Skolarikos, Andreas A.
    JOURNAL OF ENDOUROLOGY, 2017, 31 (01) : 100 - 109
  • [8] Efficacy of Tamsulosin 0.4 mg/day in Relieving Double-J Stent-related Symptoms: a Randomized Controlled Study
    Navanimitkul, N.
    Lojanapiwat, B.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2010, 38 (04) : 1436 - 1441
  • [9] TAMSULOSIN, SOLIFENACIN, AND THEIR COMBINATION FOR THE TREATMENT OF STENT-RELATED SYMPTOMS: A RANDOMIZED CONTROLLED STUDY.
    Zhou, Peng
    Zhu, Jingyu
    Li, Ruipeng
    JOURNAL OF UROLOGY, 2019, 201 (04): : E224 - E224
  • [10] Relief of double-J stent-related symptoms: a comparison between mirabegron, tamsulosin and solifenacin
    Elmarakbi, Akrm A.
    Elsayed, Osama M.
    Mohamed, Tamer R.
    Lotfy, Amr M.
    BENI-SUEF UNIVERSITY JOURNAL OF BASIC AND APPLIED SCIENCES, 2024, 13 (01)
12345